At the recent IMPAKT Breast Cancer Conference, 2 – 4th May, Brussels, ecancer´s Peter Goodwin talks to Ana Vivancos about her pioneering research in cancer genomics and work contributing to improved phase I clinical studies and best therapies for patients.
Related Posts
The Lancet Oncology: multicenter phase II PAMELA trial evidences HER2-E breast cancer as predictor of response to dual blockade therapy without chemotherapy
Findings reported from the open-label, single-group, and mulitcenter phase II PAMELA trial, published last week in The Lancet Oncology*, have…
27 Feb 2017
VHIO´s Enriqueta Felip´s expertise and international standing set to benefit the International Association for the Study of Lung Cancer
The International Association for the Study of Lung Cancer (IASLC), has recently announced ten new expert additions to its Board…
05 Jul 2017
Laura Soucek awarded prestigious AICR grant to develop anti-cancer therapies through Myc inhibtion
The Association for International Cancer Research (AICR) – now rebranded as Worldwide Cancer Research – has awarded one of its prestigious…
03 Jun 2013
Advancing precision diagnostics in oncology: VHIO to co-develop novel Next-Next Generation Sequencing
• Six Barcelona-based research entities to develop Next-Next Generation Sequencing (NNGS) platform to advance cancer and infectious disease diagnostics •…
11 Jul 2016
Molecular Oncology News and Views: VHIO-Fritz Bender Foundation International Symposium on Progress Towards Individualized Cancer Treatments, 07 – 09 November 2013
Molecular Oncology 8 (2014) 1-8 News and views Towards individualized cancer therapy: Challenges and prospects Ezzie Hutchinson ABSTRACT At the…
14 Feb 2014
Latest ESMO study reveals alarming disparities in availability and accessibility of anti-cancer therapies across Europe
Recently published as a Special Article in the flagship journal of the European Society of Medical Oncology (ESMO), Annals of…
05 Aug 2016
The New England Journal of Medicine coming to town: register now to attend the next VHIO Meet the Editors
VHIO Meet the Editors with The New England Journal of Medicine: Monday 14 May 2012
The New England Journal of Medicine´s Bette Phimister, Deputy Editor, will join us to deliver the next in the prestigious series of VHIO Meet the Editors talks:
Publishing Advances in Cancer Research
Bette Phimister will review progress and pitfalls in cancer research and issues concerning its publication, with a focus on targeted therapies and an eye to future developments.
13 Mar 2012
VHIO on the ground presenting at this year´s ASCO Annual Meeting: a hand-pick of highlights
Many of VHIO´s leading clinical investigators are currently participating at the 2017 Annual Meeting of the American Society of Clinical…
03 Jun 2017
A third consecutive year closes with VHIR recognition of upcoming VHIO talent
For the third year in a row VHIO´s Mouse Models of Cancer Therapies Group, led by Laura Soucek, has been awarded…
30 Dec 2015
Ramucirumab improves overall survival in patients with metastatic colorectal cancer and could be an option in second-line therapy
• The RAISE study, published ahead of print in today´s online version of The Lancet Oncology, is a global Phase…
14 Apr 2015
Medical research safeguarded in Europe
ESMO welcomes the adoption of the Clinical Trials Regulation by the European Union Source: The European Society for Medical Oncology…
16 Jun 2014
First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment
• The new study published in Cancer Discovery, the flagship journal of the American Association of Cancer Research (AACR), involving…
24 Feb 2013
Gastrointestinal Cancers Symposium 2015: findings from a phase III study indicate a possible new treatment strategy for patients with advanced colorectal cancer
Results from an international phase III study of patients with advanced colorectal cancer, a disease which is especially difficult to…
16 Jan 2015
Spanish periodical EL MUNDO reveals its top 25 of the most influential Spanish Citizens in Medicine for 2014
Each year, in January, the Spanish periodical EL MUNDO publishes its selection of the 500 most influential Spanish citizens for that…
10 Jan 2014
International study signposts promising therapeutic strategy to prevent resistance to RAF-MEK inhibitors
A study published in this month´s Nature Genetics, in which the Vall d’Hebron Institute of Oncology (VHIO) participated, has revealed…
16 Feb 2015
